LPS-induced mucin expression in human sinus mucosa can be attenuated by hCLCA inhibitors

Abstract

Background: hCLCA1 is a member of the calcium-activated chloride channel family and is associated with disease-inducible mucus expression. Niflumic acid (NFA) and a closely related chemical structure are reported inhibitors of calcium-activated chloride channels and endotoxin-inducible mucus expression in the mouse. Therefore, we tested the hypothesis that hCLCA1 may be involved in lipopolysaccharide (LPS) induced mucin up-regulation in human airways. We also investigated the effect of NFA and MSI-2216 on LPS-induced mucin up-regulation.

Materials and Methods : Explanted human airways and the muco-epidermoid cell line Calu-3 were stimulated with LPS. Different concentrations of NFA or MSI-2216 were added to LPS-stimulated airway mucosa and Calu-3 cells. Expression of hCLCA1 and MUC5AC mRNA and protein was quantified in human airways using real-time PCR and PAS staining. In addition, immunohistochemistry was performed for quantification of inflammatory cells (lymphocytes, monocytes, eosinophils, and neutrophils) in the submucosa of the airways. Expression of hCLCA1 protein in Calu-3 cells was analysed by FACS.

Results: LPS significantly induced hCLCA1 and MUC5AC mRNA and protein expression in human airway mucosa (P < 0.05). NFA and MSI-2216 significantly decreased LPS-induced mucus expression in explanted airway mucosa in a dose-dependent manner (P < 0.05). In Calu-3 cells, LPS significantly increased hCLCA1 surface expression whereas intracellular expression was significantly decreased (P < 0.05). In Calu-3 cells, NFA and MSI-2216 also significantly reduced MUC5AC mRNA expression (P < 0.05).

Conclusions: These data suggest that hCLCA1 may play a role in LPS-induced mucin expression in human airway mucosa. Calcium-activated chloride channel inhibitors significantly decreased LPS-induced mucus expression both ex vivo and in vitro . Therefore, blocking of hCLCA1 may offer a therapeutic approach to reduce bacterial-induced mucus hypersecretion.

Keywords

Airway hCLCA1 LPS mucus niflumic acid

References

Thorn J. The inflammatory response in humans after inhalation of bacterial endotoxin: a review. Inflamm Res 2001; 50: 254—261.

Dohrman A. , Miyata S. , Gallup M. et al. Mucin gene (MUC 2 and MUC 5AC) upregulation by Gram-positive and Gram-negative bacteria. Biochim Biophys Acta 1998; 1406: 251—259.

Yanagihara K. , Seiki M. , Cheng PW Lipopolysaccharide induces mucus cell metaplasia in mouse lung. Am J Respir Cell Mol Biol 2001 ; 24: 66—73.

Barnes PJ Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci 1998; 94: 557—572.

Lu W. , Lillehoj EP , Kim KC Effects of dexamethasone on Muc5ac mucin production by primary airway goblet cells. Am J Physiol 2005; 288: L52—L60.

Chen Y. , Nickola TJ , DiFronzo NL et al. Dexamethasone-mediated repression of MUC5AC gene expression in human lung epithelial cells. Am J Respir Cell Mol Biol 2006; 34: 338—347.

Nakano T. , Inoue H. , Fukuyama S. et al. Niflumic acid suppresses interleukin-13-induced asthma phenotypes . Am J Respir Crit Care Med 2006; 173: 1216—1221.

Nakanishi A. , Morita S. , Iwashita H. et al. Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma. Proc Natl Acad Sci USA 2001; 98: 5175—5180.

Gruber AD , Elble RC , Ji HL , Schreur KD , Fuller CM , Pauli BU Genomic cloning, molecular characterization, and functional analysis of human CLCA1, the first human member of the family of Ca2+-activated Cl— channel proteins. Genomics 1998; 54: 200—214.

10.

Zhou Y. , Dong Q. , Louahed J. et al. Characterization of a calcium-activated chloride channel as a shared target of Th2 cytokine pathways and its potential involvement in asthma. Am J Respir Cell Mol Biol 2001; 25: 486—491.

11.

Hauber HP , Daigneault P. , Frenkiel S. et al. Niflumic acid and MSI-2216 reduce TNF-alpha-induced mucin expression in human airway mucosa. J Allergy Clin Immunol 2005; 115: 266—271.

12.

Wagner JG , Harkema JR , Levitt RC , Holroyd KJ Attenuation of endotoxin-induced mucus hypersecretion and airway inflammation by MSI-2216, a calcium-activated chloride channel inhibitor (abstract). Am J Respir Crit Care Med 2003; 167: A466.

13.

Dandurand RJ , Wang CG , Laberge S. , Martin JG , Eidelman DH In vitro allergic bronchoconstriction in the brown Norway rat. Am J Respir Crit Care Med 1994; 149: 1499—1505.

14.

Minshall E. , Wang CG , Dandurand R. , Eidelman D. Heterogeneity of responsiveness of individual airways in cultured lung explants. Can J Physiol Pharmacol 1997; 75: 911—916.

15.

Goldmann T. , Vollmer E. , Gerdes J. What's cooking? Detection of important biomarkers in HOPE-fixed, paraffin-embedded tissues eliminates the need for antigen retrieval . Am J Pathol 2003; 163: 2638—2640.

16.

Hovenberg HW , Davies JR , Herrmann A. , Linden CJ , Carlstedt I. MUC5AC, but not MUC2, is a prominent mucin in respiratory secretions. Glycoconj J 1996 ; 13: 839—847.

17.

Long AJ , Sypek JP , Askew R. et al. Gob-5 contributes to goblet cell hyperplasia and modulates pulmonary tissue inflammation. Am J Respir Cell Mol Biol 2006; 35: 357—365.

18.

Gibson A. , Lewis AP , Affleck K. et al. hCLCA1 and mCLCA3 are secreted non-integral membrane proteins and therefore are not ion channels. J Biol Chem 2005; 280: 27205—27212.

19.

Leverkoehne I. , Gruber AD The murine mCLCA3 (alias gob-5) protein is located in the mucin granule membranes of intestinal, respiratory, and uterine goblet cells. J Histochem Cytochem 2002; 50: 829—838.

20.

Civelli M. , Vigano T. , Acerbi D. et al. Modulation of arachidonic acid metabolism by orally administered momiflumate in man. Agents Actions 1991; 33: 233—239.